NCT00961259View on ClinicalTrials.gov

Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric Acid

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

Fenofibric Acid 35 mg Tablet

1 x 35 mg tablet administered after an overnight fast of at least 10 hours

DRUG

Fenofibric Acid 35 mg Tablet

3 x 35 mg tablets administered after an overnight fast of at least 10 hours

DRUG

Fenofibric Acid 105 mg Tablet

105 mg tablet administered after an overnight fast of at least 10 hours

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00961259 - Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric Acid | Biotech Hunter | Biotech Hunter